Emerging Predictive and Prognostic Factors for AML

In this on-demand Webcast, Keith W. Pratz, MD, provides expert perspective on optimal treatment of patients with acute myeloid leukemia.
Keith W. Pratz, MD
Released: January 6, 2017

Information on this Educational Activity

Faculty

Keith W. Pratz, MD

Assistant Professor of Oncology
Division of Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland

Keith W. Pratz, MD, has disclosed that he has received funds for research support from AbbVie, Astellas, and Takeda Oncology.

Program Medium

This program has been made available online.

Related Content

John L. Marshall, MD
Program Director
Todd M. Bauer, MD Hagop M. Kantarjian, MD Edward S. Kim, MD, FACP Andrew D. Zelenetz, MD, PhD
Released: June 13, 2018

Downloadable PDF reviewing testing recommendations, approved agents, and companion diagnostics for TP53 del(17p) in CLL and other hematologic cancers.

John L. Marshall, MD
Program Director
Todd M. Bauer, MD Hagop M. Kantarjian, MD Edward S. Kim, MD, FACP Andrew D. Zelenetz, MD, PhD
Released: June 13, 2018

Downloadable PDF reviewing FDA-approved agents and testing strategies for FLT3-ITD and TKD mutations in AML and ALL.

John L. Marshall, MD
Program Director
Todd M. Bauer, MD Hagop M. Kantarjian, MD Edward S. Kim, MD, FACP Andrew D. Zelenetz, MD, PhD
Released: June 13, 2018

SWOG S1304 trial: twice-weekly low-dose vs high-dose carfilzomib in R/R multiple myeloma from ASCO 2018 reported by Clinical Care Options (CCO).

Released: June 11, 2018

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?